174
Views
22
CrossRef citations to date
0
Altmetric
Original

Toxicity of corticosteroids and catecholamines for mice neuronal cell cultures: Role of preservatives

, MD, , , &
Pages 325-333 | Received 15 Sep 2006, Accepted 04 Dec 2006, Published online: 07 Jul 2009
 

Abstract

Objective. To confirm previous reports on dexamethasone and sulfite neurotoxicity, and to investigate methylprednisolone, dopamine, and dobutamine neurotoxicity.

Methods. Pure dexamethasone, injectable dexamethasone containing sodium metabisulfite (Soludecadron®), pure methylprednisolone, injectable methylprednisolone (Solu-Medrol®), pure dopamine, injectable dopamine containing potassium metabisulfite (Revivan®), pure dobutamine, injectable dobutamine containing sodium metabisulfite (Dobutrex®), and sodium metabisulfite were added to the medium of mixed glial–neuronal cell cultures at concentrations of 0.1, 1, 10, and 100 μM. Cell damage induced by glucocorticoids was assessed by measuring the release of lactate dehydrogenase (LDH) from the injured cells into the extracellular fluid during the 24 hours of exposure to drugs. Cell damage induced by catecholamines was assessed using the fluorescent dye propidium iodide (PI) method 24 hours after exposure to the drugs.

Results. Methylprednisolone and Solu-Medrol did not affect neuronal death, which was increased by dexamethasone and Soludecadron at 100 μM and sodium metabisulfite at 10 and 100 μM. Neuronal death was significantly increased by dopamine, Revivan, dobutamine, Dobutrex, and sulfites at 10 and 100 μM concentrations.

Conclusions. In vitro dexamethasone, Soludecadron, and sulfites increase neuronal cell death, while methylprednisolone and Solu-Medrol are not neurotoxic; dopamine and dobutamine were found neurotoxic independently from sulfite toxicity.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.